This statistic shows the distribution of ongoing clinical trials for gene therapies and cell-based immuno-oncology (CBIO) as of end of June 2022, by therapeutic vector. The use of lentiviruses as vector was most common, making up almost half of all such trials.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Alliance for Regenerative Medicine. (September 30, 2022). Distribution of active gene therapy and CBIO trials worldwide as of 2022, by vector [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 26, 2026, from /statistics/1376858/gene-therapy-and-cbio-clinical-trials-by-vector-share/
Alliance for Regenerative Medicine. "Distribution of active gene therapy and CBIO trials worldwide as of 2022, by vector." Chart. September 30, 2022. ÌÇÐÄÆÆ½â°æ. Accessed July 26, 2026. /statistics/1376858/gene-therapy-and-cbio-clinical-trials-by-vector-share/
Alliance for Regenerative Medicine. (2022). Distribution of active gene therapy and CBIO trials worldwide as of 2022, by vector. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 26, 2026. /statistics/1376858/gene-therapy-and-cbio-clinical-trials-by-vector-share/
Alliance for Regenerative Medicine. "Distribution of Active Gene Therapy and Cbio Trials Worldwide as of 2022, by Vector." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 30 Sep 2022, /statistics/1376858/gene-therapy-and-cbio-clinical-trials-by-vector-share/
Alliance for Regenerative Medicine, Distribution of active gene therapy and CBIO trials worldwide as of 2022, by vector ÌÇÐÄÆÆ½â°æ, /statistics/1376858/gene-therapy-and-cbio-clinical-trials-by-vector-share/ (last visited July 26, 2026)
Distribution of active gene therapy and CBIO trials worldwide as of 2022, by vector [Graph], Alliance for Regenerative Medicine, September 30, 2022. [Online]. Available: /statistics/1376858/gene-therapy-and-cbio-clinical-trials-by-vector-share/